Sudbury company attracts $8M investment to support its leading-edge cancer treatment technology
A Sudbury-based company has received $8 million in private investment to support its work in cancer diagnostic technology.
Rna Diagnostics grew out of work done at Laurentian University and Health Sciences North Research Institute (HSNRI). Dr. Amadeo Parissenti, a scientist and LU professor, has developed technology that allows doctors to tell whether chemotherapy is having an impact on a patient's cancer.
"The RNA disruption assay (RDA), patented by Laurentian University and licensed to Rna Diagnostics in 2010, determines whether a patient is responding to cancer therapy, early during treatment," the company said in a news release Wednesday.
Using RDA, doctors can determine within five weeks of the start of treatment whether chemotherapy is working, allowing doctors to tailor the treatment according to the individual patient's response.
"This means that if a patient’s tumour is not responding to treatment, 80 per cent of ineffective doses and lost time can be avoided," the company said.
Rna Diagnostics has received $8 million in what's known as 'series A' financing from iGan Partners and BDC Capital. Series A financing is private funding that startup companies receive when their product or service shows enough promise to attract investment.
The discovery of RDA was made in 2007 by Parissenti and his research associate, Dr. Baoqing Guo, in their lab at HSNRI. It was patented by Laurentian University in 2010.
Rna Diagnostics’ laboratory is headquartered at HSNRI in Sudbury.
“The continued support of iGan Partners and our current investors, combined with the support of BDC Capital as a new investment partner, is exciting,” John Connolly, president and CEO of Rna Diagnostics, said in the news release.
“The closing of this series A financing will allow us to complete the pivotal validation trial (BREVITY) of the RNA Disruption Assay. BREVITY is currently recruiting patients at over 40 breast cancer centres in Europe and North America.”
Parissenti continues to study the cellular mechanisms involved in RNA disruption with Dr. Carita Lanner and Dr. Tom Kovala of the Northern Ontario School of Medicine in the hopes of finding additional tools to predict or monitor chemotherapy response and outcome in cancer patients.
“Laurentian University is proud to offer its congratulations to Dr. Parissenti and Rna Diagnostics Inc. on this incredible milestone, the investment will provide critical funding to complete the clinical trials and bring to market a technology that will improve cancer treatments worldwide while impacting positively on the quality of life of cancer patients,” Tammy Eger, Laurentian University’s vice-president, research, said in the release.
“A true northern innovation created by outstanding partnerships and collaboration.”
“This is an enormous, expensive problem for cancer centres. Typically, in solid tumors, only 30-40 per cent of patients receive a survival benefit from a given drug regimen,” Connolly added. “Patients with nonresponsive tumours (identified by the RDA) can therefore forgo the ineffective treatment and its side-effects and moved quickly to alternate treatments.”
CTVNews.ca Top Stories
Young people 'tortured' if stolen vehicle operations fail, Montreal police tell MPs
One day after a Montreal police officer fired gunshots at a suspect in a stolen vehicle, senior officers were telling parliamentarians that organized crime groups are recruiting people as young as 15 in the city to steal cars so that they can be shipped overseas.
'It was joy': Trapped B.C. orca calf eats seal meat, putting rescue on hold
A rescue operation for an orca calf trapped in a remote tidal lagoon off Vancouver Island has been put on hold after it started eating seal meat thrown in the water for what is believed to be the first time.
Man sets self on fire outside New York court where Trump trial underway
A man set himself on fire on Friday outside the New York courthouse where Donald Trump's historic hush-money trial was taking place as jury selection wrapped up, but officials said he did not appear to have been targeting Trump.
Sask. father found guilty of withholding daughter to prevent her from getting COVID-19 vaccine
Michael Gordon Jackson, a Saskatchewan man accused of abducting his daughter to prevent her from getting a COVID-19 vaccine, has been found guilty for contravention of a custody order.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.
She set out to find a husband in a year. Then she matched with a guy on a dating app on the other side of the world
Scottish comedian Samantha Hannah was working on a comedy show about finding a husband when Toby Hunter came into her life. What happened next surprised them both.
B.C. judge orders shared dog custody for exes who both 'clearly love Stella'
In a first-of-its-kind ruling, a B.C. judge has awarded a former couple joint custody of their dog.
Saskatoon police to search landfill for remains of woman missing since 2020
Saskatoon police say they will begin searching the city’s landfill for the remains of Mackenzie Lee Trottier, who has been missing for more than three years.
Shivering for health: The myths and truths of ice baths explained
In a climate of social media-endorsed wellness rituals, plunging into cold water has promised to aid muscle recovery, enhance mental health and support immune system function. But the evidence of such benefits sits on thin ice, according to researchers.